Etid klinik pou Sklerodèm nan Texas
12 etid pou Sklerodèm ap chèche patisipan nan sit nan Texas.
Vil nan Texas
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Tekton Research, Inc - West Gate Boulevard, Austin
- Arthritis & Rheumatology Institute - Frisco, Frisco
- The University of Texas Health Science Center at Houston, Houston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07497087Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- ak 2 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Denison
- GSK Investigational Site, El Paso
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Arlington, Arlington
- Artiva Investigational Site Bellaire, Bellaire
- Artiva Investigational Site Irving, Irving
- ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT06827977Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
- UT Southwestern Medical Center - Department of Dermatology, Dallas
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Jiska laj 90 · Tout sèks · Mizajou May 12, 2026 · NCT01808937Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT06434363A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site#7096, Arlington
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 31, 2026 · NCT07047690Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
- The University of Texas Health Science Center at Houston, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2025 · NCT05989763Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Dallas
- aTyr Investigative Site, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.